Inpharma Weekly

, Volume 1574, Issue 1, pp 9–10 | Cite as

Alemtuzumab superior to chlorambucil for front-line CLL therapy

Meeting report
  • 3 Downloads

Keywords

Chronic Lymphocytic Leukaemia Alemtuzumab Chlorambucil Chronic Lymphocytic Leukaemia Patient Famciclovir 

Copyright information

© Adis International Ltd 2007

Personalised recommendations